Experience
AbbVie Inc.
Sandoz Inc.
Represented AbbVie in Biologics Price Competition and Innovation (BPCIA) litigation related to Humira®.
AbbVie Inc. v. Sandoz Inc., 3:18-cv-12668, D.N.J., Judge Wolfson
Sandoz Inc. v. AbbVie Biotechnology, Ltd
AbbVie Biotechnology, Ltd
Finnegan client AbbVie secures non-institution decisions for Humira® patents
AbbVie Biotechnology, Ltd
AbbVie Inc.
AbbVie Inc.
AbbVie Inc. v. Roxane Laboratories Inc.
AbbVie Inc.
AbbVie Inc. et al v. Alvotech hf.
AbbVie Inc. et al
AbbVie Inc.
AbbVie Inc. v. Mylan Laboratories, Inc.
AbbVie Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.